Qurient Co Ltd

115180

Company Profile

  • Business description

    Qurient Co Ltd is a South Korea based biotech company. It is engaged in network research & development business model, integrating research and drug development programs with a new mechanism. Its pipeline products include Q301 for the treatment of atopic dermatitis; Q203 treats MDR/XDR/TDR TB, and Q701 is a drug-resistant cancer immuno-oncology.

  • Contact

    C-dong 8th Floor, 242, Pangyo-ro
    Bundang-gu
    Seongnam-siGyeonggi-do13487
    KOR

    T: +82 3180601600

    http://www.qurient.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    33

Stocks News & Analysis

stocks

A collection of our best stock opportunities

Our latest articles about where we see opportunities in the market.
stocks

Morningstar analyst reacts to Macquarie Group’s earnings

Banking Analyst Nathan Zaia’s analysis of MQG’s results.
stocks

Undervalued ASX share showing progress in global efforts

More clarity on the path forward in the UK.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,017.5050.800.57%
CAC 407,857.3656.480.72%
DAX 4024,217.37247.011.03%
Dow JONES (US)44,632.99204.57-0.46%
FTSE 1009,136.3254.880.60%
HKSE25,416.42108.03-0.42%
NASDAQ21,098.2980.29-0.38%
Nikkei 22540,657.4817.07-0.04%
NZX 50 Index12,963.5027.090.21%
S&P 5006,370.8618.91-0.30%
S&P/ASX 2008,758.6054.000.62%
SSE Composite Index3,626.1216.410.45%

Market Movers